- Home
- CIFR vs IART Comparison
CIFR vs IART Comparison
Compare CIFR & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIFR
- IART
- Stock Information
- Founded
- CIFR 2021
- IART 1989
- Country
- CIFR United States
- IART United States
- Employees
- CIFR N/A
- IART N/A
- Industry
- CIFR Investment Bankers/Brokers/Service
- IART Medical/Dental Instruments
- Sector
- CIFR Finance
- IART Health Care
- Exchange
- CIFR Nasdaq
- IART Nasdaq
- Market Cap
- CIFR 1.9B
- IART 1.7B
- IPO Year
- CIFR N/A
- IART 1995
- Fundamental
- Price
- CIFR $5.49
- IART $21.13
- Analyst Decision
- CIFR Strong Buy
- IART Sell
- Analyst Count
- CIFR 10
- IART 7
- Target Price
- CIFR $7.83
- IART $24.67
- AVG Volume (30 Days)
- CIFR 13.7M
- IART 489.3K
- Earning Date
- CIFR 02-25-2025
- IART 02-25-2025
- Dividend Yield
- CIFR N/A
- IART N/A
- EPS Growth
- CIFR N/A
- IART N/A
- EPS
- CIFR N/A
- IART N/A
- Revenue
- CIFR $152,466,000.00
- IART $1,564,920,000.00
- Revenue This Year
- CIFR $20.12
- IART $6.71
- Revenue Next Year
- CIFR $123.56
- IART $6.20
- P/E Ratio
- CIFR N/A
- IART N/A
- Revenue Growth
- CIFR 76.34
- IART 1.45
- 52 Week Low
- CIFR $2.66
- IART $16.81
- 52 Week High
- CIFR $7.99
- IART $45.09
- Technical
- Relative Strength Index (RSI)
- CIFR 46.95
- IART 27.91
- Support Level
- CIFR $5.85
- IART $23.67
- Resistance Level
- CIFR $6.33
- IART $24.69
- Average True Range (ATR)
- CIFR 0.48
- IART 0.89
- MACD
- CIFR 0.01
- IART -0.57
- Stochastic Oscillator
- CIFR 27.82
- IART 0.68
About CIFR Cipher Mining Inc.
Cipher Mining Inc ia an emerging technology company that operates in the Bitcoin mining ecosystem in the United States. The company is developing a cryptocurrency mining business, specializing in Bitcoin. The company is expanding and strengthening the Bitcoin network's critical infrastructure in the United States.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.